These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
187 related articles for article (PubMed ID: 11108454)
1. In vitro susceptibility of porcine respiratory pathogens to tilmicosin. DeRosa DC; Veenhuizen MF; Bade DJ; Shryock TR J Vet Diagn Invest; 2000 Nov; 12(6):541-6. PubMed ID: 11108454 [TBL] [Abstract][Full Text] [Related]
2. Minimum inhibitory concentration breakpoints and disk diffusion inhibitory zone interpretive criteria for tilmicosin susceptibility testing against Pasteurella multocida and Actinobacillus pleuropneumoniae associated with porcine respiratory disease. Shryock TR; Staples JM; DeRosa DC J Vet Diagn Invest; 2002 Sep; 14(5):389-95. PubMed ID: 12296390 [TBL] [Abstract][Full Text] [Related]
3. Mutant prevention and minimum inhibitory concentration drug values for enrofloxacin, ceftiofur, florfenicol, tilmicosin and tulathromycin tested against swine pathogens Actinobacillus pleuropneumoniae, Pasteurella multocida and Streptococcus suis. Blondeau JM; Fitch SD PLoS One; 2019; 14(1):e0210154. PubMed ID: 30629633 [TBL] [Abstract][Full Text] [Related]
4. Whole Genome Sequence Analysis of Pig Respiratory Bacterial Pathogens with Elevated Minimum Inhibitory Concentrations for Macrolides. Dayao DA; Seddon JM; Gibson JS; Blackall PJ; Turni C Microb Drug Resist; 2016 Oct; 22(7):531-537. PubMed ID: 26981707 [TBL] [Abstract][Full Text] [Related]
5. Antimicrobial susceptibility and genetic relatedness of respiratory tract pathogens in weaner pigs over a 12-month period. Niemann L; Müller P; Brauns J; Nathaus R; Schäkel F; Kipschull K; Höltig D; Wendt M; Schwarz S; Kadlec K Vet Microbiol; 2018 Jun; 219():165-170. PubMed ID: 29778191 [TBL] [Abstract][Full Text] [Related]
6. In-vitro antibacterial properties of tilmicosin against Australian isolates of Pasteurella multocida and Actinobacillus pleuropneumoniae from pigs. Blackall PJ; Asakawa T; Graydon RJ; White M; Adamson M; Wade LK; Lowe LB Aust Vet J; 1995 Jan; 72(1):35-6. PubMed ID: 8787526 [No Abstract] [Full Text] [Related]
8. Postantibiotic and physiological effects of tilmicosin, tylosin, and apramycin at subminimal and suprainhibitory concentrations on some swine and bovine respiratory tract pathogens. Diarra MS; Malouin F; Jacques M Int J Antimicrob Agents; 1999 Aug; 12(3):229-37. PubMed ID: 10461841 [TBL] [Abstract][Full Text] [Related]
9. Antibacterial activity of tilmicosin against Pasteurella multocida and Actinobacillus pleuropneumoniae isolated from pneumonic lesions in swine. Inamoto T; Kikuchi K; Iijima H; Kawashima Y; Nakai Y; Ogimoto K J Vet Med Sci; 1994 Oct; 56(5):917-21. PubMed ID: 7865594 [TBL] [Abstract][Full Text] [Related]
10. Proposed quality control guidelines for antimicrobial susceptibility tests using tilmicosin. Shryock TR; White DW; Werner CS; Staples JM J Clin Microbiol; 1995 Feb; 33(2):331-5. PubMed ID: 7714188 [TBL] [Abstract][Full Text] [Related]
11. Monitoring of antimicrobial susceptibility of respiratory tract pathogens isolated from diseased cattle and pigs across Europe, 2009-2012: VetPath results. El Garch F; de Jong A; Simjee S; Moyaert H; Klein U; Ludwig C; Marion H; Haag-Diergarten S; Richard-Mazet A; Thomas V; Siegwart E Vet Microbiol; 2016 Oct; 194():11-22. PubMed ID: 27102206 [TBL] [Abstract][Full Text] [Related]
12. Interpretive criteria for antimicrobial susceptibility testing of ceftiofur against bacteria associated with swine respiratory disease. Burton PJ; Thornsberry C; Cheung Yee Y; Watts JL; Yancey RJ J Vet Diagn Invest; 1996 Oct; 8(4):464-8. PubMed ID: 8953533 [TBL] [Abstract][Full Text] [Related]
13. Antimicrobial susceptibility monitoring of respiratory tract pathogens isolated from diseased cattle and pigs across Europe: the VetPath study. de Jong A; Thomas V; Simjee S; Moyaert H; El Garch F; Maher K; Morrissey I; Butty P; Klein U; Marion H; Rigaut D; Vallé M Vet Microbiol; 2014 Aug; 172(1-2):202-15. PubMed ID: 24837878 [TBL] [Abstract][Full Text] [Related]
15. Minimum inhibitory concentration breakpoints and disk diffusion inhibitory zone interpretive criteria for tilmicosin susceptibility testing against Pasteurella spp. associated with bovine respiratory disease. Shryock TR; White DW; Staples JM; Werner CS J Vet Diagn Invest; 1996 Jul; 8(3):337-44. PubMed ID: 8844577 [TBL] [Abstract][Full Text] [Related]
16. Tilmicosin enteric granules and premix to pigs: Antimicrobial susceptibility testing and comparative pharmacokinetics. Xiong J; Zhu Q; Zhao Y; Yang S; Cao J; Qiu Y J Vet Pharmacol Ther; 2019 May; 42(3):336-345. PubMed ID: 30801755 [TBL] [Abstract][Full Text] [Related]
17. In vitro activity of five tetracyclines and some other antimicrobial agents against four porcine respiratory tract pathogens. Pijpers A; Van Klingeren B; Schoevers EJ; Verheijden JH; Van Miert AS J Vet Pharmacol Ther; 1989 Sep; 12(3):267-76. PubMed ID: 2810475 [TBL] [Abstract][Full Text] [Related]
18. Antibacterial activity against porcine respiratory bacterial pathogens and in vitro biocompatibility of essential oils. LeBel G; Vaillancourt K; Bercier P; Grenier D Arch Microbiol; 2019 Aug; 201(6):833-840. PubMed ID: 30955056 [TBL] [Abstract][Full Text] [Related]
19. Antimicrobial resistance genes in Actinobacillus pleuropneumoniae, Haemophilus parasuis and Pasteurella multocida isolated from Australian pigs. Dayao D; Gibson JS; Blackall PJ; Turni C Aust Vet J; 2016 Jul; 94(7):227-31. PubMed ID: 27349882 [TBL] [Abstract][Full Text] [Related]
20. Evaluation of the antimicrobial activity of florfenicol against bacteria isolated from bovine and porcine respiratory disease. Shin SJ; Kang SG; Nabin R; Kang ML; Yoo HS Vet Microbiol; 2005 Mar; 106(1-2):73-7. PubMed ID: 15737475 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]